Sobi to Showcase Scientific advances and Commitment to Haematology at ASH 2025

Sobi® (STO: SOBI), today announced its participation at the 65th American Society of Hematology (ASH) Annual Meeting, taking place on 6 – 9 December in Orlando, Florida. At this year’s meeting, Sobi will showcase its commitment to advancing care in haematology with 19 scientific abstracts, including two oral presentations. These feature the most recent clinical data and insights from completed and ongoing studies across Sobi’s innovative portfolio including data from efanesoctocog alfa, pegcetac...

Invitation to presentation of Sectra’s six-month report 2025/2026

Linköping, Sweden – November 28, 2025 – International medical imaging IT and cybersecurity company Sectra (http://www.sectra.com/) (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s six-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CET) on December 12, 2025Report presentation: 10:00 a.m. (CET) on the same dateTo participate, follow the instructions on Sectra’s website inves...

Sectra at RSNA 2025: Supporting subspecialty workflows and photon-counting CT at the workstation to reduce burnout risk and improve patient care

Linköping, Sweden – November 24, 2025 – At this year’s Radiological Society of North America’s annual meeting (RSNA), international medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) will present new developments designed to make radiology workflows even more efficient, not least by deep integration with AI. Sectra will showcase its entire enterprise imaging solution that provides a unified platform for all imaging needs—while offering unique CT features, sub...

Original-Research: Sto SE & Co. KGaA (von Montega AG): Kaufen

^Original-Research: Sto SE & Co. KGaA - von Montega AG20.11.2025 / 15:15 CET/CESTVeröffentlichung einer Research, übermittelt durch EQS News - ein Serviceder EQS Group.Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.Erstel...

EQS-News: Umsatz der Sto SE & Co. KGaA in den ersten neun Monaten 2025 konzernweit 1,5 % unter Vorjahr (deutsch)

Umsatz der Sto SE & Co. KGaA in den ersten neun Monaten 2025 konzernweit 1,5 % unter Vorjahr^EQS-News: Sto SE & Co. KGaA / Schlagwort(e): 9-Monatszahlen/ZwischenberichtUmsatz der Sto SE & Co. KGaA in den ersten neun Monaten 2025 konzernweit 1,5% unte...

Ihre wichtigsten Termine: Spannende Updates von: NVIDIA, Target, Sage Group, Sto, Nokia und Novartis!

© Foto: Dall-EGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 08:00 Uhr, Groß...

German health network chooses Sectra to improve diagnostics and reduce risk of radiology burnout

Linköping, Sweden – November 11, 2025 – International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) will provide the radiology module of its enterprise imaging solution to Xcare Group, a health network in Germany. The solution will be implemented at all 12 sites and will allow radiologists to review cases within a single application, with all necessary tools easily accessible. This will significantly enhance productivity and foster collaboration across t...

Clinically meaningful pivotal study results for olezarsen in sHTG presented as a late breaker at AHA Scientific Sessions

Sobi® (STO: SOBI) today announced that, the TIMI Study Group today has presented positive results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG) at the American Heart Association 2025 Scientific Sessions. The studies met the primary endpoint, with olezarsen achieving a highly statistically significant placebo-adjusted mean reduction in fasting triglyceride (TG) levels of up to 72% at six months. The reductions were sustained through...

Sectra adds Smith+Nephew 3D templates to its orthopaedic solution—supporting wider adoption of digital surgical planning

Linköping, Sweden – October 16, 2025 – International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world’s leading medical equipment companies, Smith+Nephew. Extending the range of templates in Sectra’s solution supports a broader adoption of digital pre-operative planning, a key enabler of patient-specific treatments, which improves operationa...

Sto Vz: Die perfekte Aktie, um den Bau-Turbo in Deutschland zu spielen - drei Gründe!

Der Bundestag hat den Bau-Turbo beschlossen. Notwendig ist dieser, da das Ziel von 400.000 neuen Wohnungen in den letzten Jahren kolossal verfehlt wurde. Studien zeigen sogar einen Bedarf an bis zu 1,2...

Der Weg für den Wohnungsbau-Turbo ist frei. Ist der Startschuss für den Sto Vz. gefallen?

Die neue Regierung hat versprochen mit dem "Wohnungsbau-Turbo" das Problem von zu wenig Wohnraum zu lösen. Die fertiggestellten Wohnungen sanken in den letzten Jahren von 294.400 in 2023 auf 251.900 Einheiten...

Orexo US Awarded USD 8 Million by BARDA for OX390 Development Partnership

Uppsala, Sweden – September 29, 2025 – Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY), todayannounced its wholly owned US subsidiary, Orexo US, Inc., has been awarded USD 8 millionin funding by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response in the US Department of Health and Human Services. The funding will support the development of OX390, an intranasal rescue medication for adulterated opioid overdoses.T...

TRYNGOLZA® (olezarsen) recommended for EU approval by CHMP for familial chylomicronemia syndrome (FCS)

· Recommendation based on Phase 3 Balance results, which showed a significant reduction of triglycerides and substantial reduction of acute pancreatitis events with TRYNGOLZA · European Commission decision expected by Q4 2025 Sobi® (STO: SOBI) and Ionis Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion of TRYNGOLZA® (olezarsen) as an adjunct to diet in adult patients for the ...

Correction: Sivers Semiconductors AB (publ), publishes Interim Report Q2, April – June 2025

With reference to the press release issued on July 17th at 8:00 CET, please note that a typographical error was identified in one of the figures in the English version of the Q2 report. Specifically, the correction pertains to the bullet point on page 2 regarding the AEBITDA number. Sivers is therefore providing a link to the revised Q2 report. Another Strong Quarter With Continued Revenue Momentum, Strong Operational Execution And Coverage Initiation From Carnegie Investment Bank Kista, Sweden...

Sivers Semiconductors AB (publ), Publishes Interim Report Q2, April – June 2025

Another Strong Quarter With Continued Revenue Momentum, Strong Operational Execution And Coverage Initiation From Carnegie Investment Bank Kista, Sweden – 17 July 2025 – Sivers Semiconductors (https://www.sivers-semiconductors.com/) AB (STO:SIVE), a global leader in photonics and wireless technologies today announced another strong quarter with significant Q2 2025 results, as we scale operations and accelerate product deliveries in response to continued momentum, as well as growing customer dema...

Aker ASA: Aker Property Group Completes Exchange of Class B Shares for Class A Shares in Samhällsbyggnadsbolaget i Norden AB

Fornebu, 10 July, 2025. Aker Property Group AS, a wholly owned subsidiary of Aker ASA, today announces that its wholly owned subsidiary APG Invest AS (APG) has completed the transaction to exchange 125,038,756 class B shares (ISIN: SE0009554454) for 100,923,623 class A shares in Samhällsbyggnadsbolaget i Norden AB (STO: SBB) (“SBB”), announced on May 27, 2025. APG now holds 100,923,623 class A shares and 55,523,175 class B shares in SBB, corresponding to approximately 8.63 percent of the shares ...

One of the largest multi-region healthcare systems in the US expands enterprise imaging cloud service from Sectra with pathology to leverage integrated diagnostics in cancer care

Linköping, Sweden and Shelton, CT – July 7, 2025 – International medical imaging IT and cybersecurity company Sectra’s (https://sectra.com/) (STO: SECT B) module for digital pathology will be used by a US-based health system serving a multi-million strong patient community. This is an expansion of the healthcare provider’s usage of Sectra’s enterprise imaging solution as a cloud service, Sectra One Cloud. Together with the radiology and ophthalmology modules used today, the service now also equi...

Number of shares and votes in Orexo

Uppsala, Sweden – June 30, 2025 - Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces that, during June 2025, the number of shares and votes in the company has changed as a result of the issue and repurchase of class C shares as announced on June 18, 2025. In total, the number of shares has increased by 2,446,000 class C shares and the votes have increased by 244,600. Today, the last trading day of the month, there are in total 37,156,639 shares in Orexo - whereof 34,710,639 are ordinary sh...

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease

· Approval based on the pooled analysis of our pivotal EMERALD and NI-0501-06 studies, showing 54% of patients treated with Gamifant achieved complete response at week 8. Sobi® (STO: SOBI) today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant® (emapalumab-lzsg) for the treatment of adult and pediatric (newborn and older) patients with hemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS) in known or suspected Still’s disease, including sys...

Sobi will showcase extensive research and clinical outcomes at ISTH 2025

Sobi® (STO: SOBI) will be presenting a wide range of clinical study updates at the annual International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington (21-25 June). With ten (10) presentations, Sobi’s clinical teams will showcase new data for avatrombopag to treat children with ITP, surgery outcomes using efanesoctocog alfa, and abstracts on specific long-term haemophilia studies. “Attending ISTH is an important part of our commitment to collaboration and knowledge sharing ...

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will feature the latest advances in the treatment of diffuse large B-cell lymphoma (DLBCL), immune thrombocytopenia (ITP), myelofibrosis, paroxysmal nocturnal haemoglobinuria (PNH), and primary hemophagocytic lymphohistiocytosis (pHLH). An extensive programme of poster presentations will showcase Sobi’s commitment to helping patients with rare diseas...

Sobi and Apellis: Aspaveli®/Empaveli® Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney Diseases

Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 VALIANT study, investigating Aspaveli® (pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).The data were presented as part of a late-breaking session at the European Renal Association (ERA) Congress. In the VALIANT study, Aspaveli demonstrated a statistically significant 68% proteinuria reduction versus pl...

Der Wohnungsbau-Turbo soll vor der Sommerpause ins Bundeskabinett. Sto Vz. ist eine Comeback-Story!

Wie die dpa am 04.06.2025 unter Verweis auf Bundesbauministerin Verena Hubertz meldet, soll der der Wohnungsbau-Turbo noch vor der Sommerpause ins Bundeskabinett. Das Ziel von 400.000 neuen Wohnungen verfehlte...

Invitation to presentation of Sectra’s year-end report 2024/2025

Linköping, Sweden – May 21, 2025 – International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s year-end report with President Torbjörn Kronander and CFO Jessica Holmquist. Publication of the financial report: 8:15 a.m. (CEST) on June 5, 2025 Report presentation: 10:00 a.m. (CEST) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q...

Sto Aktie: Umsatz in Q1 rückläufig - Frühindikator Baugenehmigungen bislang mit leicht positiver Tendenz in 2025

Hamburg (www.aktiencheck.de) - Sto-Aktienanalyse von der Montega AG: Patrick Speck, Aktienanalyst der Montega AG, stuft in einer aktuellen Aktienanalyse die Vorzugsaktie der Sto SE & Co. KGaA (ISIN: DE0007274136, WKN: 727413, Ticker-Symbol: STO3) von "halten" auf "kaufen" hoch. Sto habe vergangene Woche die Zwischenmitteilung zum ersten Quartal 2025 vorgelegt. [mehr]

Original-Research: Sto SE & Co. KGaA (von Montega AG): Kaufen (zuvor: Halten)

^Original-Research: Sto SE & Co. KGaA - von Montega AG13.05.2025 / 15:53 CET/CESTVeröffentlichung einer Research, übermittelt durch EQS News - ein Serviceder EQS Group.Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.Erstel...

Sivers Semiconductors Renews Debt Financing with a U.S. Headquartered Bank to Support Growth Strategy

Kista, Sweden – May 10, 2025 – Sivers Semiconductors (https://www.sivers-semiconductors.com/) AB (STO:SIVE), a global leader in photonics and wireless technologies, today announced the successful renewal of its debt financing, securing a new three-year term loan with annual refinancing capability. The agreement is in partnership with a U.S. headquartered bank and marks a significant step in the company’s ongoing growth and financial strategy. The new loan will facilitate refinancing of the compa...

EQS-News: Sto SE & Co. KGaA: Konzernumsatz geht im ersten Quartal 2025 um 4,6 % auf 324,8 Mio. EUR zurück (deutsch)

Sto SE & Co. KGaA: Konzernumsatz geht im ersten Quartal 2025 um 4,6 % auf 324,8 Mio. EUR zurück^EQS-News: Sto SE & Co. KGaA / Schlagwort(e):Zwischenbericht/Quartals-/ZwischenmitteilungSto SE & Co. KGaA: Konzernumsatz geht im ersten Quartal 2025 um 4,...

Original-Research: Sto SE & Co. KGaA (von Montega AG): Halten (zuvor: Kaufen)

^Original-Research: Sto SE & Co. KGaA - von Montega AG05.05.2025 / 17:34 CET/CESTVeröffentlichung einer Research, übermittelt durch EQS News - ein Serviceder EQS Group.Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.Erstel...

EQS-News: Sto SE & Co. KGaA: Schwierige Marktbedingungen belasten Geschäftsverlauf 2024 (deutsch)

Sto SE & Co. KGaA: Schwierige Marktbedingungen belasten Geschäftsverlauf 2024^EQS-News: Sto SE & Co. KGaA / Schlagwort(e): Jahresergebnis/PrognoseSto SE & Co. KGaA: Schwierige Marktbedingungen belasten Geschäftsverlauf202430.04.2025 / 10:00 CET/CESTF...